Firm News

The Latest News from Lucosky Brookman

Lucosky Brookman is a leader in the representation of small and micro-cap companies. The Firm has led it clients through numerous capital raise transaction and over a dozen uplisting and initial public offering transactions.  Access the latest news about Lucosky Brookman, our clients’ business transactions and industry updates here. 

Lucosky Brookman Successfully Represents BiondVax Pharmaceuticals Ltd. in Closing of $9.8 million Follow-on Underwritten Offering of ADSs

Lucosky Brookman LLP congratulates its client, BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV) on its successful closing of an underwritten…

Read More

Lucosky Brookman Successfully Represents EF Hutton in $8.0 Million Public Offering of Applied UV, Inc.

Lucosky Brookman congratulates its client, EF Hutton on its successful public offering of $8.0 million of common stock of Applied UV, Inc.…

Read More

Lucosky Brookman LLP Successfully Represents EF Hutton in $287.5 Million Initial Public Offering of BurTech Acquisition Corp. Common Stock

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $287.5 million initial public…

Read More

Lucosky Brookman LLP Successfully Represents Australian Company, Advanced Human Imaging Limited, in a $10.5 Million Initial Public Offering of American Depositary Shares (ADS)

Lucosky Brookman LLP congratulates its Australian client, Advanced Human Imaging Limited (ASX:AHI) (NASDAQ: AHI) on its successful closing of its…

Read More

GreenBox POS Announces $100 Million Indenture Financing

Lucosky Brookman LLP is pleased to share that its client GreenBox POS (Nasdaq: GBOX) (the “Company”), an emerging fintech company that…

Read More

Lucosky Brookman LLP Successfully Represents EF Hutton in $100 Million Initial Public Offering of Energem Corp. Preferred Stock

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $100 million initial public…

Read More

Lucosky Brookman LLP Successfully Represents HeartBeam, Inc. in $16.5 Million Initial Public Offering

Lucosky Brookman LLP congratulates its client, Heartbeam, Inc. (Nasdaq: BEAT), a developmental stage digital healthcare company with a proprietary…

Read More

Lucosky Brookman Successfully Represents EF Hutton in $13 Million Initial Public Offering of Healthcare Triangle, Inc.

Lucosky Brookman congratulates its client, EF Hutton, division of Benchmark Investments, LLC, on its successful $13.0 million initial public…

Read More

Lucosky Brookman LLP Successfully Represents SurgePays, Inc. in $19.8 Million Public Offering; Uplisting to NASDAQ and Reverse Stock Split

Lucosky Brookman LLP congratulates its client, SurgePays, Inc. (Nasdaq: SURG) on its successful public offering of $19.8 million of common stock…

Read More

Lucosky Brookman LLP Successfully Represents Esports Entertainment Group, Inc. in $8 Million Public Offering of Preferred Stock

Lucosky Brookman LLP congratulates its client, Esports Entertainment Group (Nasdaq: GMBL), (Nasdaq: GMBLW) on its successful public offering of…

Read More